FRHC
Freedom Holding Corp.
FRHC offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has a slight edge over FRHC overall, supported by stronger valuation and lower modeled downside.
FRHC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FRHC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FRHC.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
FRHC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $35.61 | -77% |
| Forward | 25x | $158 | — |
| Fair | 36x | $90.74 | -43% |
| Current | 62x | $158 | — |
| Expensive | 82x | $209 | +32% |
Historical ranges are pointers, not guarantees.
FRHC's PE is in its expensive range at 62x. If earnings grow as analysts expect, today's price would be 25x next year's earnings, in its fair range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over FRHC in the historical PE scenario, which offers more potential upside but is not a forecast.
FRHC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
FRHC has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
FRHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.30 | +149% |
| Q2 2026 | $2.53 | +90% |
| Q1 2026 | $2.51 | +79% |
| Q4 2023 | $5.35 | +302% |
| Q3 2023 | $5.08 | +512% |
| Q2 2023 | $3.57 | -6.8% |
| Q1 2023 | $3.45 | -6% |
| Q4 2022 | $1.33 | -78% |
| Q3 2022 | $0.83 | -86% |
FRHC's earnings per share have fallen from their peak: $2.53 over the past year, against $6.08 in late 2021.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
FRHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $732.5M | +37% |
| Q1 2026 | $503.1M | +38% |
| Q4 2025 | $628.6M | -4.1% |
| Q3 2025 | $526.1M | -9.4% |
| Q2 2025 | $533.4M | +18% |
| Q1 2025 | $363.7M | -22% |
| Q4 2024 | $655.2M | +57% |
| Q3 2024 | $580.9M | +33% |
FRHC's revenue is growing: $733M last quarter, up 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.6% | -2 points |
| Q1 2026 | 6.2% | +49 points |
| Q4 2025 | 15% | -0.1 points |
| Q3 2025 | 12% | -11 points |
| Q2 2025 | 7.6% | -1.6 points |
| Q1 2025 | -43% | -65 points |
| Q4 2024 | 15% | -12 points |
| Q3 2024 | 22% | -8.8 points |
FRHC's operating margin was 5.6% last quarter, down 2 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over FRHC on profitability, with a higher operating margin.
FRHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$420.8M | -193% |
| Q1 2026 | -$1.6B | -221% |
| Q4 2025 | $651.7M | +$744.4M |
| Q3 2025 | $456.4M | +$903.8M |
| Q2 2025 | $450M | -46% |
| Q1 2025 | $1.3B | +330% |
| Q4 2024 | -$92.7M | -$54.2M |
| Q3 2024 | -$447.5M | -$1.1M |
FRHC's free cash flow was −$884M over the past year, against $1.2B the year before. Free cash flow isn't a meaningful measure for financial services companies like FRHC.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM has the edge over FRHC on cash flow, with more consistent year-over-year improvement.
FRHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +152K shares |
| 1 year | +0.3% | +212K shares |
| 3 years | +4.8% | +2.8M shares |
FRHC has 61M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2022 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over FRHC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
FRHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | -2.8x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
| Q3 2024 | -0.8x | Net Cash |
FRHC has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
FRHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 67.7 | Neutral |
FRHC's weekly RSI is 48 (neutral) and its Stochastic is 68 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
FRHC PE vs Financial Services Sector
| Metric | FRHC | Sector median | Relative |
|---|---|---|---|
| PE | 62x | 13x | 380% above |
| PE % | 75 | 63 | 12 pts above |
FRHC is trading at 62x earnings, a 380% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over FRHC on valuation relative to its sector.
FRHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $173.9 | 9.1% below |
| 20 week MA | $165.5 | 4.5% below |
| 50 week MA | $147.5 | 7.1% above |
| 100 week MA | $149.1 | 6% above |
| 200 week MA | $116.0 | 36% above |
FRHC has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 36% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over FRHC on trend strength, trading above more of its moving averages.
FRHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.9 | $52.1 | +250% |
| 2021 | $52.1 | $69.2 | +33% |
| 2022 | $69.2 | $57.9 | -16% |
| 2023 | $57.9 | $80.6 | +39% |
| 2024 | $80.6 | $129.7 | +61% |
| 2025 | $129.7 | $131.3 | +1.2% |
| 2026 YTD | $131.3 | $158.0 | +20% |
FRHC has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.